Anh Tran

Anh Tran is the Head of Clinical Operations at Trishula Therapeutics and is responsible for overseeing departmental infrastructure, as well as strategic clinical program planning and execution for TTX-030. She brings with her over 15 years of experience in early- to late-phase clinical development.

Prior to joining Trishula at its inception, she served as a Director of Clinical Operations at Tizona Therapeutics overseeing the TTX-030 program. Previously, Anh held positions with increasing responsibilities at Adverum Biotechnologies, Iovance Biotherapeutics and Pharmcyclics (an AbbVie company). While at Pharmcyclics, she contributed to the development and execution of the IMBRUVICA® (ibrutinib) pivotal studies and New Drug Application to the U.S. Food and Drug Administration, along with global regulatory filings for several hematology indications.

Earlier in her career, Anh held various positions in clinical operations at small-mid size biotech companies. Anh holds a Bachelor of Science in Nutrition from the University of California Davis.